Brent Saunders (Richard Drew, AP Images)

Ab­b­Vie gets the FTC's di­vid­ed bless­ing for its $63B Al­ler­gan buy­out — free­ing Brent Saun­ders to blaze a new path

It may have tak­en a lit­tle longer than ex­pect­ed, or seemed like an ar­ti­fact from the pre-pan­dem­ic era. How­ev­er, Ab­b­Vie got the

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA